The Efficacy of Ramucirumab in the Treatment of Gastric or Gastroesophageal Junction Cancer: A Meta-Analysis of RCTs

Figure 3

(a) Pooled analysis of progression-free survival (PFS) comparing the application of ramucirumab (RAM) alone or plus chemotherapy with the control (placebo or chemotherapy). (b) Pooled analysis of PFS comparing the application of RAM alone or plus chemotherapy with chemotherapy alone.

(a)

(b)